Elevance Health is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies’ health plans.
Elevance Health’s 5 highest-earning executives in 2023
By Rylee Wilson
Elevance Health CEO Gail Boudreaux was paid $21.9 million in total compensation in 2023, up from $20.9 million in 2022.
The company’s CEO-to-employee pay ratio was 389:1 in 2023, according to regulatory documents the company filed March 29.
Here were the company’s five highest-paid executives in 2023:
President and CEO Gail Boudreaux
- Salary: $1,600,000
- Stock awards: $11,850,043
- Option awards: $3,950,036
- Non-equity incentive plan: $3,648,000
- Other compensation: $840,960
- Total compensation: $21,889,039
CFO Mark Kaye
- Salary: $252,692
- Stock awards: $10,775,411
- Option awards: $924,613
- Non-equity incentive plan: $351,748
- Other compensation: $54,737
- Total compensation: $12,359,201
Chief Legal and Administrative Officer Blair Todt
- Salary: $833,846
- Stock awards: $5,000,648
- Option awards: $999,708
- Non-equity incentive plan: $1,155,711
- All other compensation: $123,059
- Total compensation: $8,112,972
President of Carelon and CarelonRx Peter Haytaian
- Salary: $944,231
- Stock awards: $3,225,051
- Option awards: $1,074,976
- Non-equity incentive plan: $1,314,369
- Other compensation: $419,424
- Total: $6,978,051
President of Government Health Benefits Felicia Norwood
- Salary: $944,231
- Stock awards: $3,225,051
- Option awards: $1,074,976
- Non-equity incentive plan: $1,087,754
- Other compensation: $143,396
- Total: $6,475,408
Former CFO John Gallina was also among the Elevance Health’s highest paid executives in 2023. He was paid $8.2 million in total compensation in 2023. Mr. Gallina retired from the CFO role Nov. 1 and remains a special adviser to the CEO.
Subscribe to the following topics: elevance healthceogail boudreauxcompensation2023
Latest articles on Payer:
Rising medical costs offset revenue gains for Independence Blue Cross
Centene’s scrapped East Coast campus sold
Weight loss drugs ranked by Medicare Part D spend
